In the first place, we couldn’t provide further treatment information about the TRK inhibitors in our patients with ETV6-NTRK fusion, since one patient died before she had a chance to use TRK inhibitors and the other have no evidence to use TRK inhibitors according to the current status of no tumor recurrence. The gene discussed is ETV6; the disease is neoplasm.